OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
Provided By GlobeNewswire
Last update: Aug 12, 2025
-- PIKture-01, a phase 1 clinical trial assessing OKI-219 in patients with advanced solid tumors, including breast cancer, is on track for single agent and fulvestrant combination data in Q4 2025
Read more at globenewswire.com
